2022 Impact Factor: 1.5
2023 CiteScore: 2.6
pISSN: 1735-1502
eISSN: 1735-5249
Chairman:
Mostafa Moin, M.D.
Editors-in-Chief:
Masoud Movahedi, M.D.
The Iranian Journal of Allergy, Asthma and Immunology (IJAAI) is an international peer-reviewed scientific and research journal. It aims to publish original papers, selected review articles, case-based reviews, and other articles of special interest in the fields of asthma, allergy, and immunology. The journal is an official publication of the Iranian Society of Asthma and Allergy (ISAA), supported by the Immunology, Asthma and Allergy Research Institute (IAARI), and published by Tehran University of Medical Sciences (TUMS). The journal is committed to providing high-quality materials through rigorous peer reviews and editorial comments. All articles are published in English.
IJAAI adheres to the World Association of Medical Editors' definition of editorial freedom and is a member of the Committee on Publication Ethics (COPE). The journal follows COPE's guidelines in addressing ethical misconduct.
Manuscript Submission
Authors should submit their manuscripts online at http://ijaai.tums.ac.ir. A manuscript number will be assigned, and authors are required to reference this number in all correspondence with the journal.
The journal's Instructions to Authors align with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (www.icmje.org).
In the cover letter, the corresponding author and all co-authors must sign under their own names before submitting the manuscript. Author details, affiliations, and contact information should be included in the "Metadata" section upon submission. The cover letter should include the corresponding author's personal contact information, including work and cell phone numbers.
The online submission system allows authors to track the review process in real time. The average turnaround time for the initial decision is approximately 8 weeks. For assistance with online submission, contact the editorial office (E-mail: ijaai@tums.ac.ir).
Manuscript Preparation
Manuscripts should be typed in single spacing, Times New Roman 12-point font, and with one-inch margins. All tables, figure legends, and references should be single-spaced. Arrange the manuscript components as follows: Title page, Abstract, Introduction, Materials/Patients and Methods, Results, Discussion, Acknowledgments, Conflict of Interest, References, Tables, Figures, and Figure Legends. Illustrations, figures, and tables should be placed within the text and uploaded separately as high-resolution files (SVG, EMF, AI, PDF, or TIFF).
Number all manuscript pages consecutively, starting with the title page.
Ethics and Consent
Authors must affirm that the research protocol received approval from an Ethics Committee and conforms to the Declaration of Helsinki (1995, revised in Edinburgh 2000). Clinical trial results involving human subjects must be registered with the Iranian Registry of Clinical Trials (IRCT) or equivalent registries. Informed consent from all participants is mandatory. The journal reserves the right to request related documents.
Copyright
Authors retain copyright but license exclusive rights in their article to the publisher. Authors can use their articles for non-commercial purposes, respecting personal use rights, proper attribution, and credit.
Figures, Tables, and Abbreviations
Figures and tables should be provided in high-resolution electronic formats. Abbreviations should be defined upon first use. Use superscript Arabic numerals for citations and explanations. Vancouver Reference System is adopted for citations.
Review Articles, Case-based Reviews, and Letters
The journal welcomes review articles, case-based reviews, and letters. Guidelines for narrative and systematic reviews should be followed. Letters must not exceed 1000 words, with a maximum of 15 references and one table or figure.
Proofs and Publication Charge
Authors should return proofs within 72 hours of receipt. Authors are required to pay the article processing and publication charge, as mentioned on the website.
Privacy Statement
Authors' names and email addresses will be used exclusively for journal-related purposes and will not be shared.
Submission Preparation Checklist
Authors must adhere to submission guidelines, including the completion of the copyright form and proper formatting.
Disclosure of AI Assistance in Manuscript Preparation: Ensuring Transparency and Integrity in Scholarly Communication
Authors utilizing Large Language Models (LLMs) such as ChatGPT in the preparation of their manuscripts must declare this usage both in their cover letters and at the end of their submitted texts. All submitted papers will be assessed for the probability of AI assistance. Manuscripts with AI involvement at an acceptable rate (defined by the editors) will be considered for the peer review process, while those exceeding this threshold will not proceed further. This policy emphasizes the importance of transparency in scholarly communication, ensuring the integrity of research while embracing the potential of AI technologies. By adhering to these guidelines, authors contribute to maintaining ethical standards and fostering trust within the academic community.
This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).
All the work in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |